Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vener

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|June 28, 2001
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myelomaM Colombi, A Guffanti, A Alietti, et al.
The British Journal of Dermatology|April 27, 2007
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemiaC Vener, D Soligo, E Berti, et al.
Leukemia & Lymphoma|April 7, 2000
Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosisC Vener, A Guffanti, M Pomati, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 10, 2015
Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancyE Ferrazzi, S Zullino, T Stampalija, et al.
Bone Marrow Transplantation|June 6, 2007
Treatment of refractory chronic GVHD with rituximab: a GITMO studyF Zaja, A Bacigalupo, F Patriarca, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2025
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based studyA Trama, E E Geerdes, E Demuru, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|June 28, 2001
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myelomaM Colombi, A Guffanti, A Alietti, et al.
The British Journal of Dermatology|April 27, 2007
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemiaC Vener, D Soligo, E Berti, et al.
Leukemia & Lymphoma|April 7, 2000
Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosisC Vener, A Guffanti, M Pomati, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 10, 2015
Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancyE Ferrazzi, S Zullino, T Stampalija, et al.
Bone Marrow Transplantation|June 6, 2007
Treatment of refractory chronic GVHD with rituximab: a GITMO studyF Zaja, A Bacigalupo, F Patriarca, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2025
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based studyA Trama, E E Geerdes, E Demuru, et al.
Pageof 1